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Abstract
Background: Nearly 1 in 10 in the population experience fatigue of more than six months at any one time.
Chronic fatigue is a common reason for consulting a general practitioner, and some patients report their
symptoms are not taken seriously enough. A gap in perceptions may occur because doctors underestimate the
impact of fatigue on patients’ lives. The main aim of the study is to explore the economic impact of chronic
fatigue in patients seeking help from general practitioners and to identify characteristics that explain variations in
costs.
Methods: The design of study was a survey of patients presenting to general practitioners with unexplained
chronic fatigue. The setting were 29 general practice surgeries located in the London and South Thames regions
of the English National Health Service. Use of services over a six month period was measured and lost
employment recorded. Regression models were used to identify factors that explained variations in these costs.
Results: The mean total cost of services and lost employment across the sample of 222 patients was £3878 for the
six-month period. Formal services accounted for 13% of this figure, while lost employment accounted for 61% and
informal care for 26%. The variation in the total costs was significantly related to factors linked to the severity of
the condition and social functioning.
Conclusions: The economic costs generated by chronic fatigue are high and mostly borne by patients and their
families. Enquiry about the functional consequences of fatigue on the social and occupational lives of patients may
help doctors understand the impact of fatigue, and make patients feel better understood.
Background
A quarter of the population report tiredness as being a
recent health problem [1], and for about 1 in 10 people
such fatigue is chronic lasting more than six months [2].
If fatigue lasts longer than 6 months, causes important
disability, is accompanied by other symptoms, but is
unexplained it has been labelled chronic fatigue syn-
drome/myalgic encephalitis (CFS/ME) [3]. Fatigue is
seen by many patients as a consequence of modern life
and is usually self-managed. A diary study of women
patients showed that only 1 in 400 episodes led to a
consultation with a doctor [4]. When they do seek clini-
cal help, most people believe there is a physical rather
than a psychological cause to their fatigue, although a
physical cause is only identified by GPs in about a fifth
of cases [5]. Physical as well as psychosocial factors need
to be explored before symptoms can be defined as
‘medically unexplained’ [6]. Doctors may take physical
and psychological factors into account. However
patients report that doctors do not take their experience
of fatigue symptoms and its impact seriously [3,7,8].
One of the reasons for this could be that doctors do not
see and therefore are not aware of the real impact of
the condition in the life of the patients. The perception
of a gap in understanding can undermine the therapeu-
tic relationship [3,7,8]. Some of the gap in perceptions
may be caused by lack of enquiry or awareness of the
social and economic cost.
Fatigue has been shown to result in high economic
costs to society, especially because of its impact on
employment and the need for families and friends to
spend time caring for the individual [9]. The aims of
this paper are (i) to explore the costs of chronic fatigue
in a sample of patients attending general practitioners in
the south east of England and (ii) to identify the factors
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associated with these costs. Such cost estimates allow
the ‘burden’ of the condition to be estimated and can
serve as a comparator for costs that arise after treat-
ments have been delivered.
Methods
Setting and sample
Participants for the study were recruited from 29 gen-
eral practice surgeries in the London and South Thames
National Health Service region. The practices covered a
population of approximately 236,000 people. Between
November 2003 and October 2007 patients presenting
at these general practice surgeries complaining of
chronic fatigue were referred by doctors if they fulfilled
the following criteria. Patients had to: (i) have had fati-
gue for more than 3 months, (ii) have a score greater
than 4 on a 11-item self-reported Chalder fatigue scale
which has been shown to be valid and reliable [10], (iii)
be aged between 16 and 75, and (iv) have had no recent
change to any drug regimen, normal full blood count,
erythrocyte sedimentation rate and thyroid function test.
The duration criteria of more than 3 months (instead of
the usual 6 months used by specialists as a minimum
criteria in the diagnosis of chronic fatigue syndrome)
was used with the aim of recruiting patients who would
represent the type of patients presenting with chronic
fatigue in general practice. Exclusion criteria were: (i)
psychotic illness, (ii) organic brain syndrome or sub-
stance dependency, (iii) presence of physical health pro-
blems that could explain the fatigue or could
contraindicate the use of graded exercise, and (iv)
already in receipt of treatment for fatigue from a psy-
chiatrist, counsellor, psychologist, community psychia-
tric nurse, physiotherapist or exercise specialist. Once
the eligibility of the patients had been confirmed, a
research associate gained written consent and collected
the different measures to be used in the study.
Clinical variables
The clinical condition of the patients was measured
using the Chalder fatigue scale [10]. The Hospital Anxi-
ety and Depression Rating Scale [11] was used to collect
the depression and anxiety levels of the patients. The
Work and Social Adjustment Scale (WASA), a self-rated
measure, was used to evaluate the impact of the condi-
tion on the patient’s life [12].
Service use and costs
The use of services by patients in the six months before
interview was measured using an adapted version of the
Client Service Receipt Inventory [13]. Patients were
asked to provide details of health and social care ser-
vices used (including number of contacts and where
appropriate the average duration). Services included
primary and secondary healthcare contacts, complemen-
tary healthcare, social care, medication and tests/investi-
gations. Additionally, patients were asked whether their
contacts with professionals were due specifically to fati-
gue although all contacts were considered in the analy-
sis. Unpaid informal care received by the patients as a
consequence of their fatigue was also recorded. Patients
stated how many hours per week family members or
friends had helped with different tasks specifically
because of the patient’s fatigue.
These service use data were combined with appropri-
ate unit costs for 2006/2007 obtained from national
sources [14-16]. The unit costs of complementary and
alternative therapies were obtained from other publica-
tions and sources [17-19]. Informal carers are not paid
for their time, but clearly there is a value to their time.
We used the replacement cost method for estimating
the hidden cost of informal care, with the unit cost of a
homecare worker being used as a proxy value (or ‘sha-
dow price’). This was based on the assumption that if
the informal carer were unavailable a homecare worker
would be the most likely formal service required to per-
form these tasks. The costs of different medicines were
obtained from the British National Formulary for the
year 2006 [20].
Production costs
Patients were also asked about their salaries (if in work)
and whether they had had to stop or reduce work due
to their ill health and if so for how many days or hours
per week during the previous six months. This informa-
tion was used to calculate the productivity losses gener-
ated by the condition, assuming that individual levels of
earnings reflect productivity, based on the human capital
approach [21]. The result was multiplied by 0.8 to
reflect the likelihood that reduced work time results in a
less than proportionate reduction in productivity [22].
Analyses
Costs were reported in the following three categories: (i)
formal service costs, (ii) all service costs (i.e. including
informal care), and (iii) total costs (i.e. including produc-
tion costs). Service costs are also disaggregated into ser-
vice categories (contacts with health and care
professionals, inpatient care, tests and medication).
Multiple regression models were constructed to iden-
tify factors that explained variation in costs chronic fati-
gue. The dependent variables were the three measures
of costs described above (formal services, all services
and total costs). Demographic factors included in the
models were gender, age, whether the patient cared for
any dependants, and whether the patient lived alone. A
variable reflecting the patients’ perceptions of the cause
of their fatigue (psychological or physiological) was
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included. Also included were the duration of the fatigue
and functional impairment measured through the Work
and Social Adjustment Scale (WASA),. Clinical factors
included: total symptom score as measured by the
Chalder Fatigue Scale, and depression and anxiety scores
measured using the Hospital Anxiety and Depression
Rating Scale. All variables were entered into the model
in a single block. Cost data are often positively skewed,
therefore generalised linear models with a log link and
gamma errors were used [23].
Sensitivity analyses
As there is uncertainty around a number of unit costs,
sensitivity analyses were performed to examine how
costs changed when the unit costs were varied. In the
case of informal care, rather than the cost of a homecare
worker used in the base-case analysis, it was assumed a
cost per hour equivalent to the national minimum wage
(£5.35). In the valuation of production costs it was
assumed first that the fall in production was greater
than the level of the wage, using a wage-production
ratio of 1.2. Second, it was assumed that this ratio was
0.4, implying that 50% of employees would be able to
make up for their lost time on their return to work.
Inclusion of the WASA in the regression models may
mask the impact that other variables have on cost.
Therefore, in sensitivity analyses we repeated the model
but excluded the WASA scores.
Ethics
The research protocol for this study was reviewed and
approved by the Multi Centre Research Ethics Commit-
tee (MREC) West Midlands (MREC/02/7/71) and was
approved by Lambeth, Southwark and Lewisham Pri-
mary Care Trusts (RDLSLG 142).
Results
Sample characteristics, service use and costs
The number of patients referred by GPs was 324. Of
these, 100 did not meet the eligibility criteria and were
excluded and 2 removed their consent. Therefore, data
were collected for 222 patients. The characteristics of
the sample are shown in Table 1. The majority were
female, living with others and did not have any depen-
dants. The mean duration of fatigue was high, at four-
and-a-half years. However this was influenced in part by
8 participants who reported fatigue of over 20 years
duration, being the median 26 months.
All except one patient had contacts with their GP dur-
ing the six-month period prior to interview (Table 2) -
an expected finding given that population were recruited
from primary care. There were a high number of con-
tacts with psychologists and physiotherapists for other
symptoms by those patients who accessed these services.
Almost one-fifth of patients reported having used com-
plementary healthcare services.
Table 3 shows the six-month mean service and lost
production costs. Over half of the estimated cost of con-
tacts with health and care professionals is related to
non-chronic fatigue reasons. Apart from contacts with
professionals, the other categories of healthcare costs
account for a small proportion of cost. The cost of med-
ication is very low at around £3 per month, with drugs
for depression and anxiety accounting for most of this
expenditure. Inpatient care, although expensive when it
is used, accounted for just 5.9% of healthcare costs due
to the relatively low numbers who were admitted. For-
mal service costs represented only 13% of the total.
Informal care was required by almost a third of
patients, and for these patients this amounted to an
average of eight hours per week. Informal care
accounted for just over a quarter (26.4%) of the total
costs. More than half of the patients stated that their
health had affected the number of hours that they were
able to work or study and this resulted in a mean lost
employment cost of £2350 during the six-month period.
This accounts for just over 60% of the total economic
cost.
Factors associated with costs
The distribution of total costs is shown in Figure 1,
illustrating the skewness of the data. Most of the sample
had relatively low costs with a few patients having sub-
stantially higher costs. With regard to healthcare costs,
having at least one dependant reduced health care cost
by 23%, after controlling for the other characteristics,
while higher levels of functional impairment resulted in
higher costs (Table 4). When all service costs were
included as the dependent variable, costs were higher
Table 1 Demographic and clinical characteristics of
sample (n = 222)
Characteristic N (%)
Male 48 (21.6)
Lives alone 41 (18.5)
Has dependants 73 (32.9)
Physical attribution of chronic fatigue 126 (56.8)
Mean (sd)
Age (years) 39.8 (13.8)
Duration of fatigue (months) 52.9 (69.5)
Depression scorea (0-21) 7.8 (3.8)
Anxiety scorea (0-21) 9.2 (4.3)
Fatigue casenessb (0-11) 9.1 (2.0)
Fatigue scoreb (0-33) 24.6 (4.7)
Work and Social Adjustment Scale (0-32) 18.2 (7.8)
a; Hospital Anxiety and Depression (HAD) scale. b; Chalder Fatigue
Questionnaire
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for women than men, and higher costs were also asso-
ciated with living with others and having a higher func-
tional impairment score. Higher total costs (i.e.
including production costs) were associated with greater
severity of chronic fatigue and functional impairment.
The variation explained by the models was 8%, 28% and
28% respectively.
Sensitivity analyses
If the national minimum wage is used to cost informal
care rather than the cost of a homecare worker there is
a 17.5% reduction in costs. There would be a 30%
increase in costs if it was assumed that the fall in pro-
duction was greater than the level indicated by wage
rates and a 30% decrease if it was assumed that 50% of
employees would be able to make up for their lost time
on their return to work. The regression analysis without
WASA scores (not shown) did not result in substantial
differences in the health care cost model. In the analysis
of service and total costs, the removal of the WASA
variable from the model did modify the findings. The
Chalder fatigue score became statistically significant for
service costs and the variable indicating the level of
depression was significant associated with total costs.
The level of variation explained by the models was
reduced significantly, with values of 6%, 12% and 15%
respectively for health care, service and total costs.
Discussion
The total economic cost associated with chronic fatigue
is high, with informal care and lost productivity as a
result of reduced work being the main contributors. The
sensitivity analyses show that the total costs are extre-
mely sensitive to the unit costs used for informal care
and the method to value the lost production. Other stu-
dies have also shown the majority of costs due to
chronic fatigue are ‘hidden costs’ such as informal care
[9,24,25]. McCrone et al, reported informal care costs
Table 2 Contacts with professionals and costs in six months prior to assessment (2006/07 £s)
Service N % Mean number of
contacts*
SD Mean cost
(all patients)
SD
General practitioner 221 99.5 4.9 2.9 231 139
Nurse 57 25.7 1.8 1.3 4 9
Pharmacist 22 9.9 2.4 1.6 8 29
Physiotherapist 17 7.7 4.2 3.5 5 24
Psychologist 17 7.7 9.4 7.2 45 205
Psychiatrist 8 3.6 2.5 1.8 13 79
Neurologist 8 3.6 1.1 0.4 6 34
Other doctor (including Accidents & Emergency) 63 28.4 2.3 1.7 64 137
Complementary and alternative therapy 40 18 6.5 7.2 43 143
Professionals allied to medicine 18 8.1 5 7.3 16 98
*by those using service
Table 3 Mean cost of services and lost production in six
months prior to assessment (2006/07 £s)
Category N (%) Mean (£) SD %
Healthcare 222 (100) 506 459 13.0
Contacts with professionals 222 (100) 436 385 86.3
Chronic fatigue related 212 (95.5) 194 259 44.5
Non-chronic fatigue related 191 (86.0) 243 306 55.6
Inpatient care 13 (5.9) 30 162 5.9
Tests/investigations 205 (92.3) 22 58 4.3
Medication 85 (38.3) 18 49 3.5
Informal care 67 (30.2) 1022 2459 26.4
Production costs 125 (56.3) 2350 3477 60.6
Total costs 3878 4573
Figure 1 Total Cost of Chronic Fatigue.
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were more substantial than those due to lost productiv-
ity [24]. Other studies have highlighted the overall mag-
nitude of the economic burden generated by chronic
fatigue syndrome, estimated at £3.5 billion for the UK
[26] and between $17 and $24 billion for the USA [27].
As far as we know this is the largest study of the costs
of chronic fatigue conducted in the UK. It improves on
previous work (e.g. [24]) in that a longer cost period is
included and the distribution of costs is more appropri-
ately reflected in the regression models.
Nearly a fifth of patients had used complementary and
alternative therapies professionals, which is very similar
to reports in the United States [28,29], Australia [30]
and the UK [9,27]. This figure may be the result of
patients who are turning to other avenues for care and
help when faced with a health care system that does not
satisfy their concerns and needs. This implies a group of
fatigue patients feel the health service is not only deny-
ing people effective healthcare [3] but also means that
they have to fund this care from their own pocket,
increasing the financial burden on them and possibly
exposing them to risk from unproven interventions
practiced by (often) unregulated practitioners.
Over one-quarter of the variation in total service costs
and costs including lost employment could be explained.
This percentage is similar to the one found in a previous
chronic fatigue study [24]. In the case of service costs,
the fact that not living alone implies a higher cost might
be explained by the effect of having a carer or helper
available and its effect on informal care costs. Women
had higher service costs than men, which may indicate a
greater willingness for them to seek help for fatigue.
Higher WASA scores implied higher costs of healthcare
with and without informal care and also costs including
lost production. This scale reflects the impact of fatigue
on patients’ lives and thus this association with costs is
what would be expected. Together with the score that
measures the severity of the fatigue these were the only
two variables that could significantly explain the varia-
tion among individuals on total costs. Whilst associa-
tions between higher costs and greater severity and
social problems were expected, it was of interest that
other factors were not significant as the duration of fati-
gue or the age of the patients.
Limitations
There are limitations to the study. First, there is a lack
of a clear consensus as to how to calculate production
costs. We used the most common method, the human
capital approach, but different values for lost production
were explored in sensitivity analyses. Questions in the
CSRI were used to measure lost work time. The CSRI is
adapted for each study but these questions have been
used in numerous other studies. However, we did not
measure the effect of reduced efficiency at work (’pre-
senteeism’) and so the production costs are likely to be
an underestimate. Second, patient recall was used for
measuring service utilisation and lost employment. This
may not always be accurate, however data from patient
recall can correlate well with data from other sources
[31,32]. Third, the study recruited patients from 29 gen-
eral practices in London and the South East of England.
Although this ensured that urban, rural and inner city
areas were included, the sample may still not be repre-
sentative of the wider population, especially regarding
salaries used to calculate the lost production, which
tend to be higher in the London and the South East
than other parts of the UK. There is also a small per-
centage of patients (12.6%) with a duration fatigue
shorter than the 6 months period in which the use of
services and lost productivity were collected. Neverthe-
less, when analysing the factors associated with cost var-
iation, the duration of fatigue was included in the
regression and therefore the results controlled by this
Table 4 Generalised linear models to identify variables associated with cost variations
Health care costs
(R2 = 0.08)
Service costs
(R2 = 0.28)
Total Costs
(R2 = 0.28)
Variable Coef p Coef p Coef p
Age (years) 0.001 0.763 -0.002 0.743 -0.004 0.551
Male (1 = yes, 0 = no) -0.134 0.363 -0.508 0.015 -0.024 0.907
Dependants (1 = yes, 0 = no) -0.235 0.083 0.297 0.121 0.078 0.674
Living alone (1 = yes, 0 = no) -0.101 0.548 -0.542 0.017 0.015 0.945
Duration of fatigue (month) -0.001 0.246 0.000 0.923 0.001 0.178
Physical attribution of fatigue (1 = yes, 0 = no) -0.079 0.522 0.047 0.800 -0.078 0.668
Chronic fatigue score 0.008 0.598 0.038 0.111 0.056 0.016
Depression score 0.016 0.476 -0.024 0.453 0.031 0.300
Anxiety score 0.011 0.469 0.021 0.360 0.018 0.418
Functional impairment (WASA) 0.022 0.022 0.062 <0.001 0.060 <0.001
Service Costs are equal to Health care costs plus informal care costs. Total costs include service costs and production costs.
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factor. Finally, an economic evaluation comparing differ-
ent therapeutic alternatives would be more useful for
the purpose of choosing between them. Nevertheless,
cost-of-illness studies, as this one, do indicate the gen-
eral economic burden of illnesses and focus attention
on those that result in high resource costs. This may
act as an indicator for the prioritisation of economic
research.
Conclusions
The cost of formal services is only a small proportion of
the overall costs for patients with chronic fatigue. Peo-
ple with chronic fatigue frequently receive care from
their families and experience lost employment. These
two features account for the greatest proportion of
costs. These findings reinforce the point that healthcare
professionals need to be aware of the real economic
strain imposed on a person with chronic fatigue and
their family, and that this can have serious implications
such as the breakdown of relationships [7]. Document-
ing the economic burdens and how they are sustained
can help health care workers to understand the causes
and consequences, and show the empathy that is pro-
vided to patients with other conditions, but which is
perceived to be lacking by patients with chronic fatigue
syndrome [8].
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